MedTech Dive July 16, 2024
The changes are part of a broader reorganization intended to increase organizational agility and help the agency meet user fee commitments.
Dive Brief:
- The Food and Drug Administration said Monday it has reorganized the Center for Devices and Radiological Health.
- FDA officials have restructured offices focused on communication and clinical evidence, creating a new division and turning an existing group into a “super office.”
- The FDA said the changes are intended to help the agency meet its Medical Device User Fee Amendments (MDUFA) V commitments and strategic priorities.
Dive Insight:
The FDA has restructured its drug and device operations in recent years to support its work to meet user fee goals. On the device side, the...
Today's Sponsors
Today's Sponsor